Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion evidence source_evidence_literature NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion SIO_000772 21738581 NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion wasDerivedFrom befree-20140225 NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion wasGeneratedBy ECO_0000203 NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.